Sanofi and GalaxoSmithKline May Have Known Zantac Could Cause Cancer

Covering up the potential harm their products may be causing is a billion-dollar business for some companies

Tuesday, April 6, 2021 - In the age of conspiracy theories, it is getting more difficult to choose which stories to believe and which ones are conjecture. One of the more heinous potential coverups is when a corporation knows that its product could kill people and looks the other way because they will make billions of dollars in profits if they can successfully cover up the medical facts. Theories have been put forward and plaintiffs have hired expert witnesses that accuse otherwise well-respected companies like Johnson & Johnson, Monsanto, and 3M of knowing for decades that their products cause cancer or injure their customers, and covering up what they knew. In all of the instances above, the Department of Justice (DOJ) has launched investigations into whether executives of the above-named companies lied to government regulators about their knowledge of cancer their products allegedly have caused. In brief, Johnson & Johnson may have known as early as 1971 that their talc supply was contaminated with asbestos, which is carcinogenic, and continued to market it directly to mothers and their babies. Monsanto allegedly covered up facts and manipulating test results that show that glyphosate, the main ingredient in Roundup herbicide, could cause cancer. A company whistleblower and the DOJ sued 3M for knowing that the hearing protection devices they sold to the US military were too short and would not work. Zantac cancer lawyers are interviewing potential clients that want to hold Sanofi and GSK accountable for their negligence.

In the latest alleged corporate coverup, Sanofi, the maker of Zantac (ranitidine), the world's best selling heartburn and antacid medicine, is being investigated by the government for lying about their knowledge that high storage temperatures and other factors could cause ranitidine to degrade into NDMA, a highly carcinogenic compound. NDMA is best known for being given to laboratory test animals to induce cancer. If allegations against Sanofi and GlaxoSmithKline (GSK) before them are true, the company's negligence may have led to hundreds of thousands of American deaths from a wide variety of types of cancer like stomach, bladder, esophagus, colon, prostate, breast, and others. More than 15 million Americans were taking Zantac 3 times per day, every day for years before the FDA stepped in on April 1, 2020, and issued a recall of all ranitidine products. While scientists struggle to pinpoint how ranitidine degrades into NDMA, those injured allegedly by taking Zantac are stepping up to the plate. Ranitidine continues to be off of the market, and hundreds of lawsuits have been filed against Sanofi. The legal process against Sanofi and GSK is in its initial stages, and cases are being consolidated into multidistrict litigation, mainly because of the complex science that could support the plaintiff's allegation. Legal experts think that tens of thousands of Zantac Cancer plaintiffs may come forward and file lawsuits in the months to come making Zantac cancer the largest mass tort case of all time ahead of tobacco and asbestos.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.